Incorporating exclusion clauses into informed consent for biobanking.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Biobank consent preferences and implications for a mixed consent model: biomedical researchers vs. community stakeholders in a semi-urban Yoruba community, Nigeria.Frontiers in genetics · 2026
   Article
2. Health care users' acceptance of broad consent for storage of biological materials and associated data for research purposes in Uganda.Wellcome open research · 2022
   Article
3. Stem cell preservation for regenerative therapies: ethical and governance considerations for the health care sector.NPJ Regenerative medicine · 2020
   Review
4. The generic Informed Consent Service gICSJournal of translational medicine · 2020
   Article
5. A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.NPJ Regenerative medicine · 2017
   Review
6. Scientists' perspectives on consent in the context of biobanking research.European journal of human genetics : EJHG · 2015
   Article
7. Fair Shares and Sharing Fairly: A Survey of Public Views on Open Science, Informed Consent and Participatory Research in Biobanking.PloS one · 2015
   Article
8. Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases.Biopreservation and biobanking · 2013
   Review
9. Challenges in biobank governance in Sub-Saharan Africa.BMC medical ethics · 2013
   Review
10. Cancer patient perceptions on the ethical and legal issues related to biobanking.BMC medical genomics · 2013
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as